Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 5:26 pm Purchase | 2025-11-13 | 13G | Evolent Health, Inc. EVH | Rubicon Fund II LP | 5,816,123 5.210% | 5,816,123 (New Position) | Filing History |
| 2025-11-14 4:27 pm Sale | 2025-09-30 | 13G | Evolent Health, Inc. EVH | Durable Capital Partners LP | 0 0.000% | -9,118,912 (Position Closed) | Filing History |
| 2025-11-14 3:37 pm Purchase | 2025-09-30 | 13G | Evolent Health, Inc. EVH | Eventide Asset Management, LLC | 6,292,511 5.400% | 2,205,659 (+53.97%) | Filing History |
| 2025-11-05 11:35 am Purchase | 2025-09-30 | 13G | Evolent Health, Inc. EVH | FMR LLC | 9,416,813 8.000% | 2,793,582 (+42.18%) | Filing History |
| 2025-08-14 3:07 pm Sale | 2025-06-30 | 13G | Evolent Health, Inc. EVH | Eventide Asset Management, LLC | 4,086,852 3.500% | -1,990,339 (-32.75%) | Filing History |
| 2025-08-06 4:32 pm Purchase | 2025-06-30 | 13G | Evolent Health, Inc. EVH | MORGAN STANLEY MS | 8,210,410 7.000% | 8,210,410 (New Position) | Filing History |
| 2025-08-06 12:01 pm Purchase | 2025-06-30 | 13G | Evolent Health, Inc. EVH | FMR LLC | 6,623,231 5.600% | 2,100,237 (+46.43%) | Filing History |
| 2025-07-07 4:14 pm Purchase | 2025-06-27 | 13G | Evolent Health, Inc. EVH | Durable Capital Partners LP | 9,118,912 7.800% | 9,118,912 (New Position) | Filing History |
| 2025-07-07 11:58 am Sale | 2025-06-30 | 13G | Evolent Health, Inc. EVH | Wellington Management Group LLP | 442,802 0.400% | -9,993,693 (-95.76%) | Filing History |
| 2025-05-15 2:29 pm Purchase | 2025-03-31 | 13G | Evolent Health, Inc. EVH | CADIAN CAPITAL MANAGEMENT LP | 10,794,606 9.300% | 10,794,606 (New Position) | Filing History |
| 2025-05-14 4:04 pm Purchase | 2025-03-31 | 13G | Evolent Health, Inc. EVH | Eventide Asset Management, LLC | 6,077,191 5.200% | 6,077,191 (New Position) | Filing History |
| 2025-02-14 6:36 pm Sale | 2024-12-31 | 13G | Evolent Health, Inc. EVH | RA Capital Management, L.P. | 3,577,197 3.100% | -4,701,906 (-56.79%) | Filing History |
| 2025-02-10 10:25 am Sale | 2024-12-31 | 13G | Evolent Health, Inc. EVH | Wellington Management Group LLP | 10,436,495 9.000% | -3,020,457 (-22.45%) | Filing History |
| 2024-11-12 09:55 am Sale | 2024-11-08 | 13G | Evolent Health, Inc. EVH | FMR LLC | 4,522,994 3.883% | -1,797,813 (-28.44%) | Filing History |
| 2024-08-07 07:47 am Purchase | 2024-07-31 | 13G | Evolent Health, Inc. EVH | Wellington Management Group LLP | 13,456,952 11.580% | 5,143,795 (+61.88%) | Filing History |
| 2024-07-10 10:10 am Sale | 2024-07-09 | 13G | Evolent Health, Inc. EVH | FMR LLC | 6,320,807 5.429% | -6,569,922 (-50.97%) | Filing History |
| 2024-06-17 8:50 pm Purchase | 2024-06-06 | 13G | Evolent Health, Inc. EVH | RA Capital Management, L.P. | 8,279,103 7.100% | 8,279,103 (New Position) | Filing History |
| 2024-04-09 1:17 pm Sale | 2024-03-29 | 13G | Evolent Health, Inc. EVH | JPMORGAN CHASE & CO JPM | 4,679,353 4.000% | -1,184,177 (-20.20%) | Filing History |
| 2024-02-13 5:04 pm Purchase | 2023-12-29 | 13G | Evolent Health, Inc. EVH | The Vanguard Group | 10,821,331 9.410% | 1,030,515 (+10.53%) | Filing History |
| 2024-02-09 09:03 am Sale | 2024-02-08 | 13G | Evolent Health, Inc. EVH | FMR LLC | 12,890,729 11.213% | -1,750,970 (-11.96%) | Filing History |